 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 12/04/2023 |
$0.56 |
$0.60 |
$0.56 |
$0.58 |
138.80K | | 12/05/2023 |
$0.56 |
$0.59 |
$0.53 |
$0.55 |
77.90K | | 12/06/2023 |
$0.55 |
$0.59 |
$0.54 |
$0.54 |
89.70K | | 12/07/2023 |
$0.53 |
$0.54 |
$0.51 |
$0.54 |
129.40K | | 12/08/2023 |
$0.52 |
$0.57 |
$0.51 |
$0.52 |
30.90K |
|
|
| Bio-Path Holdings is a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company utilizing a technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Co.'s primary drug candidate, prexigebersen, which targets growth factor receptor-bound protein 2, initially started the efficacy portion of a Phase 2 clinical trial for untreated acute myeloid leukemia patients. Co.'s second drug candidate, Liposomal Bcl-2, targets the protein Bcl-2, which is responsible for driving cell survival in up to 60% of all cancers. Co.'s third drug candidate, Liposomal STAT3, targets the STAT3 protein. | |
|
Bio-Path Holdings (BPTH) has the following price history information. Looking back at BPTH historical stock prices for the last five trading days, on December 04, 2023, BPTH opened at $0.56, traded as high as $0.60 and as low as $0.56, and closed at $0.58. Trading volume was a total of 138.80K shares. On December 05, 2023, BPTH opened at $0.56, traded as high as $0.59 and as low as $0.53, and closed at $0.55. Trading volume was a total of 77.90K shares. On December 06, 2023, BPTH opened at $0.55, traded as high as $0.59 and as low as $0.54, and closed at $0.54. Trading volume was a total of 89.70K shares. On December 07, 2023, BPTH opened at $0.53, traded as high as $0.54 and as low as $0.51, and closed at $0.54. Trading volume was a total of 129.40K shares. On December 08, 2023, BPTH opened at $0.52, traded as high as $0.57 and as low as $0.51, and closed at $0.52. Trading volume was a total of 30.90K shares.
BPTH Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bio-Path Holdings shares, starting with a $10,000 purchase of BPTH, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
12/11/2013 |
|
| End date: |
12/08/2023 |
|
| Start price/share: |
$576.00 |
|
| End price/share: |
$0.52 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.91% |
|
| Average Annual Total Return: |
-50.40% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$9.03 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 12/04/2023 | $0.58 | | 12/05/2023 | $0.55 | | 12/06/2023 | $0.54 | | 12/07/2023 | $0.54 | | 12/08/2023 | $0.52 |
|
|
Free BPTH Email Alerts:
